SCHEMBL1018407

SCHEMBL1018407

O=C(n1nccn1)n1nccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26837515 0.73
SCHEMBL27894391 0.73
SCHEMBL28235356 0.71
SCHEMBL28325068 0.67 MGLL (0.36)
SCHEMBL28267127 0.67
SCHEMBL7381738 0.63
Pyrazine SCHEMBL27860453 0.48 NAPRT (0.47)
SCHEMBL75323 0.48
Benzene SCHEMBL10964916 0.40 CA1 (0.71)
Benzene SCHEMBL10961254 0.40 CA1 (0.71)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0019762-B1 TRIAZOLYL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PLANT GROWTH REGULATION AGENTS CONTAINING THEM BASF Aktiengesellschaft (DE) 1982-03-24 EP claimed
US-7960556-B2 Thiadiazole derivatives for the treatment of neuro-degenerative diseases NV REMYND (BE) 2011-06-14 US disclosed
EP-2094677-B1 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES REMYND NV (BE) 2011-01-12 EP disclosed
US-20100144709-A1 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES NV REMYND (BE) 2010-06-10 US disclosed
EP-2094677-A1 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES NV Remynd (BE) 2009-09-02 EP disclosed
WO-2008061781-A1 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES NV REMYND (BE) 2008-05-29 WO disclosed
CN-1968920-A Tricyclic aromatic and bis-phenyl sulfinyl derivatives CEPHALON INC (US) 2007-05-23 CN disclosed
US-5221680-A Controlling or prevention of diseases of the cardiovascular system CASSELLA AKTIENGESELLSCHAFT (DE) 1993-06-22 US disclosed
EP-0429751-B1 SUBSTITUTED 3-AMINO-SYDNONIMINES, PROCESS FOR THEIR PREPARATION AND THEIR USE CASSELLA Aktiengesellschaft (DE) 1993-06-16 EP disclosed
EP-0346694-B1 SUBSTITUTED 3-AMINOSYDNONE IMINES, PROCESS FOR THEIR PREPARATION AND THEIR USE CASSELLA Aktiengesellschaft (DE) 1993-01-27 EP disclosed
EP-0367036-A2 Substituted 3-aminosydnonimines, process for their preparation and their use CASSELLA Aktiengesellschaft (DE) 1990-05-09 EP disclosed
EP-0346684-A1 Substituted 3-aminosydnonimines, method for their preparation and their use CASSELLA Aktiengesellschaft (DE) 1989-12-20 EP disclosed
EP-0346694-A1 Substituted 3-Aminosydnone imines, process for their preparation and their use CASSELLA Aktiengesellschaft (DE) 1989-12-20 EP disclosed
EP-0327808-A1 Substituted 3-aminosydnonimines, process for their preparation and their use CASSELLA Aktiengesellschaft (DE) 1989-08-16 EP disclosed
US-4845091-A HYPOTENSIVE AGENTS, VASCULAR DISORDERS CASSELLA AKTIENGESELLSCHAFT (DE) 1989-07-04 US disclosed
EP-0312773-A2 Substituted 3-aminosydnonimines, process for their preparation and their use CASSELLA Aktiengesellschaft (DE) 1989-04-26 EP disclosed
US-4816454-A CARDIOVASCULAR DISORDERS CASSELLA AKTIENGESELLSCHAFT (DE) 1989-03-28 US disclosed
US-4684392-A Beta-triazolyl oximes agents containing them for influencing the growth of plants and their use BASF AKTIENGESELLSCHAFT (DE) 1987-08-04 US disclosed
US-4319911-A REDUCING THE STEM LENGTH BASF AKTIENGESELLSCHAFT (DE) 1982-03-16 US disclosed
US-4278800-A γ-Azolyl compounds, agents containing them for regulating plant growth, and the manufacture thereof BASF AKTIENGESELLSCHAFT (DE) 1981-07-14 US disclosed